1. Home
  2. CME
  3. Ophthalmology
advertisement

KOL KNOCKOUTTM CATARACT EDITION Beyond BCVA: Ensuring Patient Satisfaction in Refractive Outcomes

01/24/2025
1.00 credits
KOL KNOCKOUT Beyond BCVA Ensuring Patient Satisfaction in Refractive Outcomes
Choose a format
Program Information
Take Post-TestSkip straight to the post-test if you have already participated in this activity
Program Information
Take Post-Test
1.00 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Download PDF
  • Overview

    Content Source 

    This continuing medical education (CME) activity captures content from three symposia. 

    Activity Description

    This supplement summarizes a discussion on the recent advances that have improved outcomes and efficiencies in refractive cataract surgery.

     Target Audience

    This certified CME activity is designed for cataract and refractive surgeons. 

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Explain how ocular surface disease may affect biometric measurements and postoperative refractive outcomes
    • Compare current and emerging premium IOLs and summarize the latest data on potential outcomes achieved with different IOL technologies
    • Discuss updates in surgical planning systems and new technologies used to improve refractive outcomes and provide better surgical efficiency during refractive cataract surgery
    • Evaluate the potential benefits and drawbacks of using femtosecond laser technology for refractivecataract surgery
  • Grantor Statement

    This activity is supported by independent educational grants from Alcon and Johnson & Johnson Vision. 

  • Accreditation

    This educational activity is provided by Evolve Medical Education LLC (Evolve).

    Accreditation Statement

    Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation Statement

    Evolve Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Participation Method

    In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

  • Faculty and Disclosures

    Faculty

    Blake K. Williamson, MD, MPH, MS, Program Chair
    Williamson Eye Center and Outpatient Surgery Center for Sight
    Baton Rouge, LA

    Brett Mueller, DO, PhD
    Mueller Vision LASIK & Cataract Eye Surgery
    Fort Worth, TX



    Taj Nasser, MD

    Medical Director
    Tylock George Eye Care and Laser
    Mueller Vision
    Dallas-Fort Worth, TX

    Julie Marie Schallhorn, MD, MS
    University of California, San Francisco
    San Francisco, CA

    F. Beau Swann, MD, MS
    Brazos Eye Surgery of Texas
    Waco, TX

    Evan D. Schoenberg, MD
    Cornea, Cataract, and Refractive Surgeon
    Georgia Eye Partners
    Atlanta, GA

    Rahul S. Tonk, MD, MBA
    Associate Professor of Clinical Ophthalmology
    Medical Director
    Bascom Palmer Eye Institute at The Lennar Foundation Medical Center
    Co-Director Cornea & Refractive Surgery Fellowship
    University of Miami Miller School of Medicine
    Bascom Palmer Eye Institute
    Miami, FL

    William F. Wiley, MD
    Medical Director
    Cleveland Eye Clinic
    Division of Midwest Partners
    Cleveland, OH

    DISCLOSURE POLICY
    In accordance with the ACCME Standards for Integrity and Independence , it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.

    The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.

    Brett Mueller, DO, PhD, has had a financial relationship or affiliation with the following ineligible companies in the from of Consultant: Alcon, Carl Zeiss Meditec, Glaukos, Johnson & Johnson Vision, LumiBird, RxSight, STAAR Surgical, and Tarsus Pharmaceuticals. 

    Taj Nasser, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, STAAR Surgical, and Tarsus Pharmaceuticals. Grant/Research Support: STAAR Surgical.

    Julie Marie Schallhorn, MD, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Carl Zeiss Meditec, Elios, JelliSee, Neurotrigger, and Vialase. Common Stock: Journey Medical and Novus Therapeutics.

    Evan D. Schoenberg, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Lensar. Speaker's Bureau: Dompé, Glaukos, and Johnson & Johnson Vision.

    F. Beau Swann, MD, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, BioTissue, Johnson & Johnson Vision, and Ocular Therapeutix. Speaker's Bureau: Bausch + Lomb, BioTissue, Johnson & Johnson Vision, and Ocular Therapeutix. Common Stock: Ocular Therapeutix. 

    Rahul S. Tonk, MD, MBA, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Bruder Healthcare, Glaukos, Johnson & Johnson Vision, LayerBio, and Sight Sciences. Speaker’s Bureau: Johnson & Johnson Vision.  

    William F. Wiley, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Harrow, Johnson & Johnson Vision, Rayner, and RxSight. Grant/Research Support: Bausch + Lomb, BVI, and Johnson & Johnson Vision. Common Stock: Harrow Health.

    Blake K. Williamson, MD, MPH, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Bausch + Lomb, BioTissue, Carl Zeiss Meditec, Diopsys, Eyevance, Glaukos, Johnson & Johnson Vision, New World Medical, Omeros, Shire, Sight Sciences, and Sun Pharma. Speaker’s Bureau: AbbVie, Allergan, Glaukos, New World Medical, and TearLab.

    The Evolve and staff, planners, reviewer, and writers have no financial relationships with ineligible companies.

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract & Refractive Surgery Today (CRST), CRST Global, YoungMD Connect, Alcon, or Johnson & Johnson Vision.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Expiration Date:

Recommended
Details
Download PDF
  • Overview

    Content Source 

    This continuing medical education (CME) activity captures content from three symposia. 

    Activity Description

    This supplement summarizes a discussion on the recent advances that have improved outcomes and efficiencies in refractive cataract surgery.

     Target Audience

    This certified CME activity is designed for cataract and refractive surgeons. 

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Explain how ocular surface disease may affect biometric measurements and postoperative refractive outcomes
    • Compare current and emerging premium IOLs and summarize the latest data on potential outcomes achieved with different IOL technologies
    • Discuss updates in surgical planning systems and new technologies used to improve refractive outcomes and provide better surgical efficiency during refractive cataract surgery
    • Evaluate the potential benefits and drawbacks of using femtosecond laser technology for refractivecataract surgery
  • Grantor Statement

    This activity is supported by independent educational grants from Alcon and Johnson & Johnson Vision. 

  • Accreditation

    This educational activity is provided by Evolve Medical Education LLC (Evolve).

    Accreditation Statement

    Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation Statement

    Evolve Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Participation Method

    In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

  • Faculty and Disclosures

    Faculty

    Blake K. Williamson, MD, MPH, MS, Program Chair
    Williamson Eye Center and Outpatient Surgery Center for Sight
    Baton Rouge, LA

    Brett Mueller, DO, PhD
    Mueller Vision LASIK & Cataract Eye Surgery
    Fort Worth, TX



    Taj Nasser, MD

    Medical Director
    Tylock George Eye Care and Laser
    Mueller Vision
    Dallas-Fort Worth, TX

    Julie Marie Schallhorn, MD, MS
    University of California, San Francisco
    San Francisco, CA

    F. Beau Swann, MD, MS
    Brazos Eye Surgery of Texas
    Waco, TX

    Evan D. Schoenberg, MD
    Cornea, Cataract, and Refractive Surgeon
    Georgia Eye Partners
    Atlanta, GA

    Rahul S. Tonk, MD, MBA
    Associate Professor of Clinical Ophthalmology
    Medical Director
    Bascom Palmer Eye Institute at The Lennar Foundation Medical Center
    Co-Director Cornea & Refractive Surgery Fellowship
    University of Miami Miller School of Medicine
    Bascom Palmer Eye Institute
    Miami, FL

    William F. Wiley, MD
    Medical Director
    Cleveland Eye Clinic
    Division of Midwest Partners
    Cleveland, OH

    DISCLOSURE POLICY
    In accordance with the ACCME Standards for Integrity and Independence , it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.

    The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.

    Brett Mueller, DO, PhD, has had a financial relationship or affiliation with the following ineligible companies in the from of Consultant: Alcon, Carl Zeiss Meditec, Glaukos, Johnson & Johnson Vision, LumiBird, RxSight, STAAR Surgical, and Tarsus Pharmaceuticals. 

    Taj Nasser, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, STAAR Surgical, and Tarsus Pharmaceuticals. Grant/Research Support: STAAR Surgical.

    Julie Marie Schallhorn, MD, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Carl Zeiss Meditec, Elios, JelliSee, Neurotrigger, and Vialase. Common Stock: Journey Medical and Novus Therapeutics.

    Evan D. Schoenberg, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Lensar. Speaker's Bureau: Dompé, Glaukos, and Johnson & Johnson Vision.

    F. Beau Swann, MD, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, BioTissue, Johnson & Johnson Vision, and Ocular Therapeutix. Speaker's Bureau: Bausch + Lomb, BioTissue, Johnson & Johnson Vision, and Ocular Therapeutix. Common Stock: Ocular Therapeutix. 

    Rahul S. Tonk, MD, MBA, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Bruder Healthcare, Glaukos, Johnson & Johnson Vision, LayerBio, and Sight Sciences. Speaker’s Bureau: Johnson & Johnson Vision.  

    William F. Wiley, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Harrow, Johnson & Johnson Vision, Rayner, and RxSight. Grant/Research Support: Bausch + Lomb, BVI, and Johnson & Johnson Vision. Common Stock: Harrow Health.

    Blake K. Williamson, MD, MPH, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Bausch + Lomb, BioTissue, Carl Zeiss Meditec, Diopsys, Eyevance, Glaukos, Johnson & Johnson Vision, New World Medical, Omeros, Shire, Sight Sciences, and Sun Pharma. Speaker’s Bureau: AbbVie, Allergan, Glaukos, New World Medical, and TearLab.

    The Evolve and staff, planners, reviewer, and writers have no financial relationships with ineligible companies.

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract & Refractive Surgery Today (CRST), CRST Global, YoungMD Connect, Alcon, or Johnson & Johnson Vision.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Expiration Date:

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free